Erika Carmel-Tech Ltd (ERKA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Erika Carmel-Tech Ltd (ERKA) has a cash flow conversion efficiency ratio of 0.113x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.52 Million ≈ $4.07K USD) by net assets (ILA13.40 Million ≈ $35.92K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ERKA days of operational coverage to measure how many days the company can operate on defensive assets alone.
Erika Carmel-Tech Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Erika Carmel-Tech Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Erika Carmel-Tech Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Erika Carmel-Tech Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eko Export SA
WAR:EEX
|
-0.017x |
|
Global Engine Group Holding Limited Ordinary Shares
NASDAQ:GLE
|
-0.028x |
|
BioNexus Gene Lab Corp Common stock
NASDAQ:BGLC
|
-0.181x |
|
BTU Metals Corp
V:BTU
|
-0.025x |
|
Bhakti Agung Propertindo
JK:BAPI
|
-0.007x |
|
Technoplus Ventures Ltd
TA:TNPV
|
-0.040x |
|
Alchemy Resources Ltd
AU:ALY
|
-0.023x |
|
Thai-German Products Public Company Limited
BK:TGPRO
|
0.008x |
Annual Cash Flow Conversion Efficiency for Erika Carmel-Tech Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Erika Carmel-Tech Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see ERKA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA9.79 Million ≈ $26.24K |
ILA1.44 Million ≈ $3.86K |
0.147x | +152.36% |
| 2024-12-31 | ILA15.04 Million ≈ $40.31K |
ILA-4.22 Million ≈ $-11.33K |
-0.281x | +25.70% |
| 2023-12-31 | ILA23.73 Million ≈ $63.61K |
ILA-8.97 Million ≈ $-24.06K |
-0.378x | +52.26% |
| 2022-12-31 | ILA42.67 Million ≈ $114.39K |
ILA-33.80 Million ≈ $-90.61K |
-0.792x | -142.64% |
| 2021-12-31 | ILA88.06 Million ≈ $236.09K |
ILA-28.75 Million ≈ $-77.08K |
-0.326x | -116.08% |
| 2020-12-31 | ILA8.97 Million ≈ $24.05K |
ILA18.21 Million ≈ $48.81K |
2.030x | +11.65% |
| 2019-12-31 | ILA3.11 Million ≈ $8.33K |
ILA5.65 Million ≈ $15.14K |
1.818x | -- |
About Erika Carmel-Tech Ltd
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more